These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 467961)

  • 1. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats.
    Priego JG; Maroto ML; Piña M; Catalan RE
    Gen Pharmacol; 1979; 10(3):215-9. PubMed ID: 467961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
    Priego JG; Maroto ML; Piña M; Catalán RE
    Gen Pharmacol; 1979; 10(4):315-8. PubMed ID: 488666
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
    Priego JG; Maroto ML; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of etofibrate, clofibrate and nicotinic acid on the cyclic AMP-protein kinase system in rats.
    Catalán RE; Aragones MD; Martinez AM; Armijo M; Priego JG
    Gen Pharmacol; 1979; 10(6):455-8. PubMed ID: 230120
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism.
    Herrera E; Lasunción MA; Castro M; Gómez-Coronado D; Martín A; Quack G
    Biochim Biophys Acta; 1988 Nov; 963(1):42-52. PubMed ID: 3179329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
    Maier R; Muller K
    Adv Exp Med Biol; 1975; 63():349-57. PubMed ID: 1199873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents affecting lipid metabolism. XL. Effect of ethyl chlorophenoxyisobutyrate on liver lipids and serum lipoproteins in rats.
    Hill P; Dvornik D
    Can J Biochem; 1971 Aug; 49(8):903-10. PubMed ID: 5120254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of etofibrate on platelet function: in vitro studies in human plasma.
    Ortega MP; Sunkel C; Armijo M; Priego JG
    Thromb Res; 1980 Aug; 19(3):409-16. PubMed ID: 7001672
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol metabolism.
    Lancet; 1973 Mar; 1(7802):524-5. PubMed ID: 4119954
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
    Petit D; Bonnefis MT; Rey C; Infante R
    Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immediate and long term effects of clofibrate on the metabolism of the perfused rat liver.
    Laker ME; Mayes PA
    Biochem Pharmacol; 1979 Sep; 28(18):2813-27. PubMed ID: 497030
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of clofibrate on the handling of dietary and liver fat.
    Westerfeld WW; Elwood JC; Richert DA
    Biochem Pharmacol; 1972 Apr; 21(8):1117-25. PubMed ID: 5034197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs].
    Kaiser W; Zöllner N
    Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
    Filip M; Păduraru I; Hriscu A; Neacşu R; Dănilă G; Filip F
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):341-5. PubMed ID: 3685700
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
    Weithmann KU; Granzer E
    Artery; 1980; 8(5):475-81. PubMed ID: 7011266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice].
    Okada K; Mochizuki T; Shinohara Y; Takahashi S; Takagi K; Irikura T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):331-43. PubMed ID: 6745812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The lipid-reducing efficiency of a clofibrate-inositolnicotinate combination in comparison with clofibrate. The wrong use of statistical methods--presented on an example from clinical research].
    Haase W; Kluthe R; Schäfer B
    Med Welt; 1975 Nov; 26(47):2157-9. PubMed ID: 1105056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lowering lipids rapidly and permanently with etofibrate].
    von Bock und Polach U
    Med Klin; 1982 Jan; 77(3):35-8. PubMed ID: 7057729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.